Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Nupr1 Modulates Methamphetamine-Induced Dopaminergic Neuronal Apoptosis and Autophagy through CHOP-Trib3-Mediated Endoplasmic Reticulum Stress Signaling Pathway.

Xu X, Huang E, Tai Y, Zhao X, Chen X, Chen C, Chen R, Liu C, Lin Z, Wang H, Xie WB.

Front Mol Neurosci. 2017 Jun 26;10:203. doi: 10.3389/fnmol.2017.00203. eCollection 2017.

2.

Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.

Su H, Zhang J, Ren W, Xie Y, Tao J, Zhang X, He J.

Medicine (Baltimore). 2017 Apr;96(15):e6434. doi: 10.1097/MD.0000000000006434.

3.

Impulsive-antisocial dimension of psychopathy linked to enlargement and abnormal functional connectivity of the striatum.

Korponay C, Pujara M, Deming P, Philippi C, Decety J, Kosson DS, Kiehl KA, Koenigs M.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar;2(2):149-157. doi: 10.1016/j.bpsc.2016.07.004.

PMID:
28367514
4.

Structural Neuroimaging in Polysubstance Users.

Meyerhoff DJ.

Curr Opin Behav Sci. 2017 Feb;13:13-18. doi: 10.1016/j.cobeha.2016.07.006.

PMID:
28094824
5.

Altered reward expectancy in individuals with recent methamphetamine dependence.

Bischoff-Grethe A, Connolly CG, Jordan SJ, Brown GG, Paulus MP, Tapert SF, Heaton RK, Woods SP, Grant I; TMARC Group.

J Psychopharmacol. 2017 Jan;31(1):17-30. doi: 10.1177/0269881116668590. Epub 2016 Sep 27.

6.

Psychological intervention with working memory training increases basal ganglia volume: A VBM study of inpatient treatment for methamphetamine use.

Brooks SJ, Burch KH, Maiorana SA, Cocolas E, Schioth HB, Nilsson EK, Kamaloodien K, Stein DJ.

Neuroimage Clin. 2016 Aug 24;12:478-91. doi: 10.1016/j.nicl.2016.08.019. eCollection 2016.

7.

Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Mikelman S, Mardirossian N, Gnegy ME.

J Chem Neuroanat. 2016 Aug 30. pii: S0891-0618(16)30071-0. doi: 10.1016/j.jchemneu.2016.08.004. [Epub ahead of print] Review.

PMID:
27585851
8.

Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND.

PLoS One. 2016 Jun 8;11(6):e0155457. doi: 10.1371/journal.pone.0155457. eCollection 2016. Erratum in: PLoS One. 2017 Feb 8;12 (2):e0172080.

9.

Methamphetamine alters microglial immune function through P2X7R signaling.

Fernandes NC, Sriram U, Gofman L, Cenna JM, Ramirez SH, Potula R.

J Neuroinflammation. 2016 Apr 26;13(1):91. doi: 10.1186/s12974-016-0553-3.

10.

Cocaine and methamphetamine induce opposing changes in BOLD signal response in rats.

Taheri S, Xun Z, See RE, Joseph JE, Reichel CM.

Brain Res. 2016 Jul 1;1642:497-504. doi: 10.1016/j.brainres.2016.04.040. Epub 2016 Apr 18.

11.

Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction.

Ellis C, Hoffman W, Jaehnert S, Plagge J, Loftis JM, Schwartz D, Huckans M.

Addict Disord Their Treat. 2016 Mar;15(1):1-5.

12.

Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.

Mendieta L, Granado N, Aguilera J, Tizabi Y, Moratalla R.

Int J Neuropsychopharmacol. 2016 Aug 12;19(8). pii: pyw021. doi: 10.1093/ijnp/pyw021. Print 2016 Aug.

13.

Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction.

Cadoni C.

Front Neurosci. 2016 Feb 9;10:13. doi: 10.3389/fnins.2016.00013. eCollection 2016. Review.

14.

Structural imaging for addiction medicine: From neurostructure to neuroplasticity.

Brown GG, Jacobus J, McKenna B.

Prog Brain Res. 2016;224:105-27. doi: 10.1016/bs.pbr.2015.07.029. Epub 2015 Oct 27. Review.

15.

Prefrontal glutamate correlates of methamphetamine sensitization and preference.

Lominac KD, Quadir SG, Barrett HM, McKenna CL, Schwartz LM, Ruiz PN, Wroten MG, Campbell RR, Miller BW, Holloway JJ, Travis KO, Rajasekar G, Maliniak D, Thompson AB, Urman LE, Kippin TE, Phillips TJ, Szumlinski KK.

Eur J Neurosci. 2016 Mar;43(5):689-702. doi: 10.1111/ejn.13159. Epub 2016 Feb 22.

16.

Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.

Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyv129. doi: 10.1093/ijnp/pyv129. Print 2016 May.

17.

Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw PF.

J Dual Diagn. 2015;11(3-4):189-202. doi: 10.1080/15504263.2015.1100471.

18.

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE.

Pharmacol Rev. 2015 Oct;67(4):1005-24. doi: 10.1124/pr.114.010397. Review.

19.

Personality disorder symptomatology is associated with anomalies in striatal and prefrontal morphology.

Payer DE, Park MT, Kish SJ, Kolla NJ, Lerch JP, Boileau I, Chakravarty MM.

Front Hum Neurosci. 2015 Aug 31;9:472. doi: 10.3389/fnhum.2015.00472. eCollection 2015.

20.

CAMKII-conditional deletion of histone deacetylase 2 potentiates acute methamphetamine-induced expression of immediate early genes in the mouse nucleus accumbens.

Torres OV, McCoy MT, Ladenheim B, Jayanthi S, Brannock C, Tulloch I, Krasnova IN, Cadet JL.

Sci Rep. 2015 Aug 24;5:13396. doi: 10.1038/srep13396.

Supplemental Content

Support Center